Dr. Bruce T. Lamb received a BA degree in Biology from Swarthmore College, his PhD in Molecular Biology from the University of Pennsylvania, and a post-doctoral fellowship at Johns Hopkins University. In 1996, Dr. Lamb was recruited to Case Western Reserve University, where he rose from Assistant to Associate Professor and finally moved to the Cleveland Clinic in 2005. At the Cleveland Clinic, Dr. Lamb was promoted from Associate Professor to Full Professor in 2011, and later was recruited to become the Executive Director of the Stark Neurosciences Research Institute with the IU School of Medicine in January 2016. Dr. Lamb has received numerous awards and honors including the Jennifer B. Langston Award from the Cleveland Chapter of the Alzheimer’s Association, the National Civic Award, and the Zaven Khachaturian Lifetime Achievement Award from the National Alzheimer’s Association. He is a Fellow in the American Association for the Advancement of Science and a member (and Vice-Chair) of the Medical and Scientific Advisory Council of the National Alzheimer’s Association. Dr. Lamb’s laboratory works on the basic science of Alzheimer’s disease, with a focus on: 1) genetic modifiers identified from both mouse and human studies, 2) microglia and neuronal-microglial communication in the development and progression of AD pathologies; and 3) traumatic brain injury as an environmental modifier for the development of AD pathologies. Dr. Lamb is also one of the lead PIs of the NIH-funded Model Organism Development and Evaluation for Late-onset Alzheimer’s Disease (MODEL-AD) consortium. In addition, Dr. Lamb is actively involved in advocacy for increased research funding for the disease. Dr. Lamb also has a BrightFocus grant entitled The Role of TREM2 in AD Tauopathy.